欧盟发布《个案病例安全报告实施指南》
2015-07-22 MedSci MedSci原创
ISO ICSR(Individual Case Safety Report,个案病例安全报告)是一项用于提高药品疑似不良反应报告的新国际标准,该标准将于2016年7月1日生效。欧洲药品管理局(EMA)为支持这项新国际标准在欧盟(EU)的实施,近期发布了《个案病例安全报告实施指南》。ISO ICSR旨在为全球各地患者发生的涉及某种药物疑似不良反应的病例提供相同的报告格式。该标准实施后,预计有关药品
ISO ICSR(Individual Case Safety Report,个案病例安全报告)是一项用于提高药品疑似不良反应报告的新国际标准,该标准将于2016年7月1日生效。欧洲药品管理局(EMA)为支持这项新国际标准在欧盟(EU)的实施,近期发布了《个案病例安全报告实施指南》。
Individual Case Safety Reports
Description: The HL7 Individual Case Safety Report (ICSR) captures information needed to support reporting of adverse events, product problems and consumer complaints associated with the use of FDA regulated products.
ICSR Release 2 was completed December 2011 as an SDO Joint Initiative Project between the International Standards Organization (ISO), the European Committee for Standardization (CEN) and HL7. Information about the SDO Joint Initiative can be found at: http://www.jointinitiativecouncil.org/. The ICSR specification, ISO/HL7 27953 is a multi-part standard created to consolidate work efforts in ISO and HL7 as follows:
1. ISO new work item proposal N545: Health informatics - Pharmacovigilance - Structure and data elements of individual case safety report (reclassified as ISO 27953);
2. Health Level Seven (HL7) Individual Case Safety Report (ICSR) Release 1, Normative Standard;
3. HL7 ICSR Release 2, Draft Standard for Trial Use (DSTU)ISO/HL7 27953-1 (Part 1) is designed to address areas of overlap across the work items and form a messaging framework reference. This framework can be applied to support data exchange requirements described in the many different use cases presented as storyboards in this International Standard. This framework allows for future development work to be carried out so that additional use cases that are not currently addressed in this edition can be added in the future as new parts to this International Standard.
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
很不错的哦
152
这指南很有价值
188